CATS
Captopril And Thrombolysis Study

Purpose
To test the effect of angiotensin-converting enzyme (ACE) inhibition, given with thrombolytic therapy, on evolving myocardial damage due to ischaemia and the consequences of early reperfusion following AMI

References
Kingma JH, Van Gilst WH, Peels CH: Angiotensin-converting enzyme inhibition during thrombolytic therapy in acute myocardial infarction: the Captopril and Thrombolysis Study. J Cardiovasc Pharmacol 1992, 19(suppl 4):S18–S24.
Kingma JH, Van Gilst WH, Peels CH, et al: Acute intervention with captopril during thrombolysis in patients with first anterior myocardial infarction. Results from the Captopril And Thrombolysis Study (CATS). Eur Heart J 1994, 15:898–907.
Van Gilst WH, Kingma JH, Peels KH, et al: Which patients benefit from early angiotensin-converting enzyme inhibition after myocardial infarction? Results of one-year serial echocardiographic follow-up from the Captopril and Thrombolysis Study (CATS). J Am Coll Cardiol 1996, 28:114–121.

Voltar

Apoio: Libbs Farmacêutica Farmacêutica